Sparfloxacin

司帕沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameSparfloxacin
Drug Alias Name司氟沙星sparfloxacinumsparfloxacine斯巴沙星斯帕哌酸 +[15] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsBronchitis, ChronicBacterial Infections
Global Approved IndicationsBronchitis, ChronicBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1996/12/19
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMylan Nv
China Registration ClassN/A

Develop Information

Active CompaniesHanhui Pharmaceuticals Company Ltd
Inactive CompaniesMylan Nv
Active IndicationsBacterial Infections
Inactive IndicationsBronchitis, Chronic

Other Information

ATC CodeJ01MA09
Related LinksWikipediaDrugBankKEGG